Introduction: The pandemic related to the new coronavirus is characterized by high rates of contamination, transmissibility, and mortality. The measures of social isolation adopted by the World Health Organization and corroborated by several countries, with a view to avoiding or minimizing the transmission of COVID-19, can lead to the reduction of the capacity of screening and diagnosis of diseases, such as breast cancer. Objective: This study aimed to analyze the diagnostic indexes and mamaria malignancy diagnosis test, such as mammogram, during the COVID-19 pandemic period. Methodology: Systematic review of the literature based on studies found in the PubMed, SciELO, LILACS, and ScienceDirect databases. Results: The six selected articles demonstrate a reduction in the diagnosis of breast cancer during the pandemic, although with discordant rates. Outcomes such as reduced number of mammograms and change in tumor stage were also analyzed. Conclusion: It is essential to maintain care with the screening, diagnosis, and treatment of breast cancer, in order to minimize the damage caused over more than 1 year of COVID-19 pandemic.

Introduction: COVID-19 pandemic brought a major impact on cancer screening services, among those, colorectal cancer (CRC). This study evaluated the COVID-19 pandemic impact on the quantity of colonoscopies performed at different countries and its consequences. Method: Articles from PUB-MED, Scielo and LILACS databases were manually collectedbetween April 25th and June 30th of 2021. Cross-sectional, observational and retrospective studies were selected; 11 articles remained applying the inclusion and exclusion criteria. Results: There was significant reduction of colonoscopies performed during the COVID-19 pandemic demonstrated in all of the studies. A 90% reduction was shown in 3 studies, the lesser reduction was demonstrated by Challine et al., (2021), which was 20%. Also was found a reduction on CRC diagnosis during that period, 72% and 22% at UK in Rutter et al. (2021) and Morris et al., (2021), respectively. At Italy the reduction was of 11,9% as Buscarini et al., (2021) shows. Lui et al., (2020) demonstrated a 37% reduction at Hong-Kong. Conclusion: The impact of COVID-19 pandemic in CRC screening and diagnostic services was significant, increasing the morbidity and mortality due to late diagnosis. Beyond that it was observed an increase on the diagnosis probability of colonoscopy during that period. More studies are required to fully understand the impact of the screening decreased capacity.

Between 2001-2005, U.S. Blacks experienced a 32% higher pancreatic cancer death rate than Whites. Smoking, diabetes, and family history may explain some of this disparity, but prospective analyses are warranted. From 1984-2004, there were 6,243 pancreatic cancer deaths among Blacks (n=48,252) and Whites (n=1,011,864) in the Cancer Prevention Study II cohort. Multivariate Cox proportional hazards models yielded hazards ratios for known and suspected risk factors. Population attributable risks were computed and their impact on age-standardized mortality rates evaluated. Blacks in this cohort had a 42% increased risk of pancreatic cancer mortality compared to Whites (HR=1.42; 95% CI 1.28 to 1.58). Current smoking increased risk by >60% in both races; although Blacks smoked less intensely, risks were similar to Whites (HR Black =1.67, 95% CI 1.28 to 2.18; HR White =1.82, 95%CI 1.7 to 1.95). Obesity was significantly associated with pancreatic cancer mortality in Black men (HR=1.66, 95% CI 1.05 to 2.63), White men (HR=1.42; 95% CI 1.25 to 1.60) and White women (HR=1.37; 95% CI 1.22 to 1.54); results were null in Black women. The PAR due to smoking, family history, diabetes, cholecystectomy, and overweight/obesity was 24.3% in Whites and 21.8% in Blacks. Smoking and overweight/ obesity play a substantial a role in pancreatic cancer. Variation in the impact of these factors underscores the need to evaluate disease on the race-sex level. The inability to attribute excess disease in Blacks to currently known risk factors, even when combined with suspected risks, points to yet undetermined factors that play a role in the disease process.

No contexto contemporâneo de aumento da prevalência do câncer e de sobrevida ligada à doença, o trabalho pode apresentar sentidos e significados próprios, oferecendo um novo campo de estudo. Foi realizado um estudo qualitativo, de natureza exploratória e descritiva, utilizando-se de duas formas de abordagem dos sujeitos, todos trabalhadores ativos ao diagnóstico de câncer: 17 entrevistas individuais semiestruturadas, incluindo sujeitos com idades entre 28 e 61 anos e um grupo focal, composto por seis sujeitos, com idades variando entre 24 e 51 anos, por meio da aplicação de um roteiro com questões norteadoras. O conteúdo das falas foi analisado a partir das categorias preestabelecidas processos de subjetivação do trabalho para a pessoa com câncer e controle e normalidade da vida por meio do trabalho. Os participantes da pesquisa sinalizam percepções de ressignificação da vida confirmando o papel do trabalho diante do diagnóstico e do tratamento do câncer.  Palavras-chave: Câncer. Significado do Trabalho. Identidade.  Normalidade. Controle.

No abstract